Last Updated:
2:29 pm
Monday, June 23, 2025
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.
asx-acw
Market Cap
AU$63.54M
Volume
1958456
Open
0.02
AU$
High
0.02
AU$
Low
0.02
AU$
Shares On Issue
2.92B
52 Week Low
0.019
AU$
52 Week High
0.099
AU$
Website
www.actinogen.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved